Гипердиагностика при маммографии может быть ниже
Гипердиагностика при маммографии может быть ниже UA.NEWS
Онкология
Рак молочной железы
677 материалов по теме, собраны автоматически из проверенных источников
Онкология
A major risk of breast cancer screening may have been overestimated for decades
A new analysis suggests mammograms may lead to far less breast cancer overdiagnosis than some earlier studies indicated. Researchers reexamined all eight major randomized screening trials and accounted for differences in follow-up time, screening frequency, and screening after trials ended. Their results were…
🎗️
Онкология
How biology is reshaping breast cancer care
How biology is reshaping breast cancer care The Cancer Letter
🎗️
Онкология
How Paxalisib Is Being Studied in Treatment-Resistant Breast Cancer
How Paxalisib Is Being Studied in Treatment-Resistant Breast Cancer Cure Today
Онкология
Launching a Venture Philanthropy Program to Accelerate Breast Cancer Innovations - BCRF
Launching a Venture Philanthropy Program to Accelerate Breast Cancer Innovations - BCRF Oncodaily
Онкология
Wake Forest Researchers Identify a Protein That Helps Aggressive Breast Cancer Spread to the Brain
Wake Forest Researchers Identify a Protein That Helps Aggressive Breast Cancer Spread to the Brain BioBuzz
:format(jpg)/aHR0cHM6Ly94bi0tODBhaGNubGhzeGoueG4tLXAxYWkvbWVkaWEvbXVsdGltZWRpYS9tZWRpYWZpbGUvZmlsZS8yMDI1LzEyLzE4LzIwMjUxMjAyXzExNDcyNC5qcGc.jpg)
Онкология
Новый маммограф в Ногинске ускорит диагностику рака молочной железы
Новый маммограф в Ногинске ускорит диагностику рака молочной железы REGIONS.ru
Онкология
Landmark trial evaluates chemotherapy benefit in high-risk early-stage breast cancer
The addition of CDK4/6 inhibitors to endocrine therapy has changed the standard of care for patients with high-risk, early-stage estrogen receptor-positive, HER2-negative (ER+/HER2-) breast cancer by reducing the risk of recurrence. However, one patient subgroup continues to present a clinical dilemma. In current…
Онкология
New trial aims to evaluate chemotherapy benefit for ER+/HER2- breast cancer patients - News-Medical
New trial aims to evaluate chemotherapy benefit for ER+/HER2- breast cancer patients News-Medical
Онкология
Why Breast Cancer Clinical Trials Stop Early: Poor Accrual Remains the Leading Threat to Study Completion
Why Breast Cancer Clinical Trials Stop Early: Poor Accrual Remains the Leading Threat to Study Completion oncodaily.com
Онкология
Giovanni Maria Iannantuono: Key Drivers of Early Termination in Breast Cancer Clinical Trials
Giovanni Maria Iannantuono: Key Drivers of Early Termination in Breast Cancer Clinical Trials Oncodaily
🎗️
Онкология
7 Breast Cancer Clinical Trials Currently Enrolling in the US
7 Breast Cancer Clinical Trials Currently Enrolling in the US Cure Today
🎗️
Онкология
Largest Real-World Evidence Study in Early-Stage Breast Cancer; FLEX Surpasses 25,000 Patients
Largest Real-World Evidence Study in Early-Stage Breast Cancer; FLEX Surpasses 25,000 Patients Business Wire
Онкология
Insurance hinders home-injection program of breast cancer therapy
A home-injection approach for certain cancer therapies, such as gonadotropin-releasing hormone agonists for breast cancer, could substantially benefit patients, but barriers linked to insurance coverage could hinder program implementation. A pilot program for patients with breast cancer, funded by the NCI Telehealth…
Онкология
Neoadjuvant Anbenitamab/Chemotherapy Combination Improves Response in ERBB2-Positive Breast Cancer
Neoadjuvant Anbenitamab/Chemotherapy Combination Improves Response in ERBB2-Positive Breast Cancer The ASCO Post